Search

{"id":13893,"date":"2019-12-19T14:02:46","date_gmt":"2019-12-19T14:02:46","guid":{"rendered":"https://camenterprise.dev.twkmedia.com/?p=13893"},"modified":"2022-02-09T15:42:23","modified_gmt":"2022-02-09T15:42:23","slug":"learning-from-with-and-betwe

exciting new businesses take shape. ... n. n. n. n. Now we have more exciting news u2013 weu2019re expanding.

{"id":7767,"date":"2017-01-19T17:11:18","date_gmt":"2017-01-19T17:11:18","guid":{"rendered":"https://camenterprise.dev.twkmedia.com/?p=7767"},"modified":"2020-10-23T13:28:17","modified_gmt":"2020-10-23T12:28:17","slug":"annual_review_2016","status":"

{"id":9822,"date":"2017-12-20T16:27:10","date_gmt":"2017-12-20T16:27:10","guid":{"rendered":"https://camenterprise.dev.twkmedia.com/?p=9822"},"modified":"2020-10-23T13:28:55","modified_gmt":"2020-10-23T12:28:55","slug":"looking-back-looking-ahead","s

rendered":"One raven does not a winter make"},"content":{"rendered":". Recently, news broke that Circassia, an Oxford-based biotech company, had an unsuccessful phase III trial in their lead allergy-alleviating ... n. There is no schadenfreude in the

{"id":9216,"date":"2017-08-18T10:59:17","date_gmt":"2017-08-18T09:59:17","guid":{"rendered":"https://camenterprise.dev.twkmedia.com/?p=9216"},"modified":"2020-10-23T13:28:45","modified_gmt":"2020-10-23T12:28:45","slug":"cambridge-research-in-the-soci

www.enterprise.cam.ac.uk/wp-json/yoast/v1/statistics"}]}},"/yoast/v1/new-content-type-visibility/dismiss-post-type":{"namespace":"yoast/v1","methods":["POST"],"endpoints":[{"methods":["POST"],"args":{"postTypeName":{"required":false}}}],"_

Working at Cambridge Enterprise Iu2019ve learnt that the direct commercialisation of research via licensing to an existing company, or the formation of a new start-up can be an effective way ... n. Weu2019re currently looking for a new.

l.querySelectorAll('blockquote[data-secret="'t.secret+'"]'),c=new ... r=new URL(s.getAttribute("src")),n=new